| 44.2 |
132.5 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 30.4 |
121.7 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 25.4 |
304.5 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 25.3 |
76.0 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 25.2 |
100.6 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 24.5 |
146.9 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 20.6 |
61.9 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 19.8 |
336.9 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 19.5 |
58.6 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 18.8 |
131.7 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 16.8 |
50.4 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 16.5 |
65.8 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 16.3 |
48.9 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 15.8 |
15.8 |
GO:2000974 |
negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 15.1 |
45.3 |
GO:0030862 |
neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 15.1 |
90.5 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 15.0 |
105.0 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 14.4 |
43.1 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 14.3 |
28.7 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 13.9 |
27.9 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 13.9 |
41.7 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) renal vesicle induction(GO:0072034) |
| 13.8 |
41.4 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 13.7 |
54.8 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 13.0 |
156.3 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 12.9 |
12.9 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 12.7 |
38.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 12.6 |
50.4 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 12.0 |
36.1 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 12.0 |
47.8 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 11.8 |
59.2 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 11.8 |
11.8 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 11.7 |
35.0 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 11.4 |
34.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 11.1 |
33.3 |
GO:0042939 |
renal sodium ion transport(GO:0003096) glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 11.0 |
65.9 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 10.4 |
31.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 10.4 |
82.9 |
GO:0033504 |
floor plate development(GO:0033504) |
| 10.3 |
41.4 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 10.1 |
30.3 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 9.7 |
39.0 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 9.6 |
124.5 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 9.4 |
37.7 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 9.3 |
28.0 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 9.3 |
84.0 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 9.2 |
73.5 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 8.9 |
106.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 8.8 |
26.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 8.6 |
17.3 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 8.5 |
144.1 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 8.4 |
109.0 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 8.2 |
24.6 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) cardiac cell fate determination(GO:0060913) |
| 8.1 |
32.6 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 8.0 |
24.0 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 8.0 |
23.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 7.8 |
23.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 7.7 |
239.2 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 7.5 |
75.4 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 7.5 |
22.4 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 7.3 |
21.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 7.2 |
86.6 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 7.2 |
172.7 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 7.0 |
21.1 |
GO:0090526 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 7.0 |
28.0 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 7.0 |
34.9 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 6.9 |
34.3 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 6.8 |
27.4 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 6.6 |
26.6 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 6.6 |
6.6 |
GO:0060067 |
cervix development(GO:0060067) |
| 6.5 |
45.6 |
GO:0051304 |
chromosome separation(GO:0051304) |
| 6.5 |
26.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 6.5 |
71.2 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 6.3 |
18.8 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 6.2 |
25.0 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 6.1 |
30.4 |
GO:0061197 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
| 6.1 |
30.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 6.0 |
18.1 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 6.0 |
18.1 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 6.0 |
174.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 6.0 |
6.0 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 6.0 |
30.0 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 5.9 |
17.7 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 5.9 |
46.9 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 5.7 |
56.9 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 5.7 |
17.0 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 5.6 |
22.6 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 5.5 |
11.1 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 5.4 |
16.3 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 5.4 |
16.2 |
GO:0042637 |
catagen(GO:0042637) |
| 5.3 |
85.0 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 5.3 |
47.5 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 5.2 |
20.8 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 5.2 |
20.7 |
GO:0051595 |
response to methylglyoxal(GO:0051595) |
| 5.1 |
25.4 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 5.0 |
25.2 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 5.0 |
65.3 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 5.0 |
34.9 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 4.8 |
33.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 4.8 |
23.8 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 4.7 |
28.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 4.7 |
14.1 |
GO:0009202 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
| 4.6 |
13.9 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 4.6 |
23.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 4.6 |
9.1 |
GO:0038091 |
VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 4.5 |
13.6 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 4.5 |
13.5 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 4.3 |
12.8 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 4.2 |
29.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 4.2 |
8.4 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 4.2 |
12.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 4.1 |
8.3 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 4.1 |
8.2 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 4.1 |
12.3 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 4.1 |
8.1 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 4.0 |
16.0 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 3.9 |
66.5 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 3.9 |
11.7 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 3.9 |
11.6 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 3.9 |
30.8 |
GO:0034433 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 3.8 |
15.2 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 3.8 |
11.4 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 3.7 |
11.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 3.7 |
18.7 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 3.7 |
11.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 3.7 |
7.4 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 3.6 |
58.4 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 3.6 |
18.0 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 3.6 |
14.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 3.6 |
25.0 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 3.5 |
10.6 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 3.5 |
14.0 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 3.5 |
124.9 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 3.5 |
3.5 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 3.4 |
17.2 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 3.4 |
44.4 |
GO:0007530 |
sex determination(GO:0007530) |
| 3.4 |
23.9 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 3.4 |
40.6 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 3.3 |
3.3 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 3.3 |
10.0 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 3.3 |
29.9 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 3.3 |
16.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 3.3 |
19.5 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 3.2 |
9.7 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 3.2 |
9.7 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 3.2 |
22.5 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 3.2 |
19.1 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 3.1 |
9.4 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 3.1 |
12.4 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 3.1 |
21.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 3.1 |
12.2 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 3.0 |
30.4 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 3.0 |
24.3 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 2.9 |
11.8 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 2.9 |
64.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 2.9 |
8.8 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 2.9 |
34.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 2.9 |
31.5 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 2.8 |
14.2 |
GO:2001053 |
regulation of mesenchymal cell apoptotic process(GO:2001053) |
| 2.8 |
62.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 2.8 |
25.3 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 2.8 |
2.8 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 2.8 |
8.4 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 2.8 |
25.2 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 2.8 |
16.7 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 2.7 |
10.8 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 2.7 |
8.0 |
GO:0009177 |
glycine biosynthetic process(GO:0006545) deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 2.6 |
31.2 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 2.6 |
10.4 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 2.6 |
23.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 2.6 |
15.5 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 2.6 |
25.7 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 2.6 |
25.7 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 2.6 |
5.1 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 2.5 |
2.5 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) |
| 2.5 |
10.0 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 2.5 |
10.0 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 2.5 |
10.0 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 2.5 |
10.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 2.5 |
19.9 |
GO:0045187 |
regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 2.5 |
7.4 |
GO:0045590 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of regulatory T cell differentiation(GO:0045590) |
| 2.4 |
12.1 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) cellular response to potassium ion starvation(GO:0051365) |
| 2.4 |
7.3 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 2.4 |
4.8 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 2.4 |
9.7 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 2.4 |
4.8 |
GO:0060066 |
oviduct development(GO:0060066) |
| 2.4 |
26.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 2.4 |
14.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 2.4 |
9.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 2.4 |
54.3 |
GO:0007099 |
centriole replication(GO:0007099) |
| 2.4 |
18.9 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 2.4 |
9.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 2.4 |
18.8 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 2.3 |
39.8 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 2.3 |
7.0 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 2.3 |
9.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 2.3 |
4.6 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 2.3 |
782.2 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 2.2 |
4.5 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 2.2 |
8.9 |
GO:0070244 |
negative regulation of thymocyte apoptotic process(GO:0070244) |
| 2.2 |
6.6 |
GO:2000768 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 2.1 |
17.1 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 2.1 |
4.3 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 2.1 |
17.0 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 2.1 |
19.0 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 2.1 |
8.4 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 2.1 |
12.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 2.1 |
8.3 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 2.1 |
26.8 |
GO:0007098 |
centrosome cycle(GO:0007098) |
| 2.1 |
6.2 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 2.0 |
6.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 2.0 |
6.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 2.0 |
8.0 |
GO:0002339 |
B cell selection(GO:0002339) |
| 2.0 |
46.2 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 2.0 |
8.0 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 2.0 |
4.0 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 2.0 |
39.7 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 2.0 |
4.0 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 2.0 |
41.3 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 2.0 |
7.8 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 2.0 |
7.8 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 2.0 |
3.9 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 1.9 |
9.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 1.9 |
3.8 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 1.9 |
32.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 1.9 |
15.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 1.9 |
17.1 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 1.9 |
7.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 1.9 |
5.6 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 1.8 |
5.5 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.8 |
3.7 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.8 |
12.8 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 1.8 |
5.4 |
GO:0034384 |
positive regulation of lipoprotein particle clearance(GO:0010986) high-density lipoprotein particle clearance(GO:0034384) |
| 1.8 |
10.7 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 1.8 |
41.0 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 1.8 |
14.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.8 |
21.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 1.8 |
70.6 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 1.7 |
1.7 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 1.7 |
38.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 1.7 |
3.4 |
GO:0060161 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 1.7 |
12.0 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 1.7 |
3.4 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 1.7 |
3.4 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 1.7 |
17.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 1.7 |
8.5 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 1.7 |
5.0 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 1.7 |
10.0 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 1.7 |
23.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 1.7 |
6.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.7 |
14.9 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 1.6 |
4.9 |
GO:0050000 |
chromosome localization(GO:0050000) |
| 1.6 |
3.3 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 1.6 |
9.9 |
GO:0009409 |
response to cold(GO:0009409) |
| 1.6 |
4.8 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 1.6 |
4.8 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.6 |
6.3 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 1.6 |
7.8 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 1.6 |
9.4 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 1.6 |
4.7 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 1.6 |
1.6 |
GO:0034238 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
| 1.5 |
3.1 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 1.5 |
10.7 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.5 |
9.1 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 1.5 |
10.6 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 1.5 |
9.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 1.5 |
24.1 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 1.5 |
3.0 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.4 |
4.3 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 1.4 |
15.9 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 1.4 |
1.4 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 1.4 |
7.1 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 1.4 |
9.9 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 1.4 |
8.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 1.4 |
4.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 1.4 |
2.8 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 1.4 |
8.3 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 1.4 |
19.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 1.4 |
4.1 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 1.4 |
5.5 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 1.4 |
2.7 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 1.3 |
6.7 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 1.3 |
6.7 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 1.3 |
4.0 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 1.3 |
4.0 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 1.3 |
12.0 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.3 |
14.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.3 |
6.5 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 1.3 |
15.4 |
GO:0045165 |
cell fate commitment(GO:0045165) |
| 1.3 |
16.5 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 1.3 |
12.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 1.3 |
3.8 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 1.3 |
2.5 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 1.2 |
3.7 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 1.2 |
7.5 |
GO:0060065 |
uterus development(GO:0060065) |
| 1.2 |
4.9 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 1.2 |
8.6 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 1.2 |
1.2 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 1.2 |
3.6 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 1.2 |
3.6 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 1.2 |
16.7 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 1.2 |
21.4 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 1.2 |
19.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 1.2 |
3.5 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 1.2 |
5.9 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 1.1 |
6.9 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 1.1 |
12.6 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 1.1 |
1.1 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 1.1 |
1.1 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 1.1 |
3.3 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 1.1 |
8.7 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.1 |
2.2 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.1 |
4.2 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 1.1 |
39.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 1.1 |
4.2 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 1.1 |
5.3 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 1.1 |
6.3 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 1.1 |
2.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 1.1 |
6.3 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 1.0 |
3.1 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 1.0 |
3.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 1.0 |
9.3 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 1.0 |
5.1 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 1.0 |
2.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.0 |
18.4 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 1.0 |
4.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 1.0 |
19.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 1.0 |
3.0 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 1.0 |
6.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.0 |
3.0 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 1.0 |
6.0 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 1.0 |
3.0 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 1.0 |
10.8 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 1.0 |
7.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 1.0 |
1.0 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 1.0 |
1.0 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 1.0 |
11.6 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 1.0 |
10.6 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 1.0 |
3.8 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 1.0 |
1.0 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.9 |
21.6 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.9 |
5.6 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
| 0.9 |
13.8 |
GO:1901976 |
regulation of cell cycle checkpoint(GO:1901976) regulation of DNA damage checkpoint(GO:2000001) |
| 0.9 |
4.6 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.9 |
14.5 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.9 |
2.7 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.9 |
6.2 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.9 |
21.9 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.9 |
4.4 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.9 |
8.7 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.9 |
9.5 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.9 |
2.6 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.9 |
5.1 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.8 |
18.6 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.8 |
8.4 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.8 |
1.7 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.8 |
20.7 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.8 |
7.4 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.8 |
2.5 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.8 |
13.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.8 |
3.3 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.8 |
3.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.8 |
0.8 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.8 |
26.8 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.8 |
2.4 |
GO:0032375 |
negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
| 0.8 |
8.0 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.8 |
3.2 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.8 |
16.6 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.8 |
49.8 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.8 |
15.7 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.8 |
6.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.8 |
3.8 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.8 |
13.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.8 |
1.5 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.8 |
2.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.7 |
23.1 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.7 |
14.1 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.7 |
2.2 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.7 |
2.2 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.7 |
5.8 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.7 |
7.3 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.7 |
75.7 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.7 |
4.2 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.7 |
6.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.7 |
2.8 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.7 |
2.8 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.7 |
2.8 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.7 |
2.8 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.7 |
2.1 |
GO:0071865 |
regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
| 0.7 |
4.8 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.7 |
1.4 |
GO:0002839 |
positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
| 0.7 |
2.0 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.7 |
11.3 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.7 |
1.3 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.7 |
9.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.6 |
1.9 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.6 |
1.9 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.6 |
3.2 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.6 |
3.2 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.6 |
4.4 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.6 |
5.6 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.6 |
1.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.6 |
1.8 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.6 |
7.9 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.6 |
2.4 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.6 |
5.4 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.6 |
5.4 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.6 |
1.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.6 |
4.1 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.6 |
16.4 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.6 |
3.5 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.6 |
1.7 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.6 |
8.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.6 |
1.7 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.6 |
7.8 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.6 |
16.3 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.6 |
2.8 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.5 |
2.2 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.5 |
1.1 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.5 |
1.6 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.5 |
6.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.5 |
11.0 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.5 |
5.7 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.5 |
2.6 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.5 |
4.5 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.5 |
1.0 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.5 |
19.7 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.5 |
0.5 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.5 |
6.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.5 |
5.8 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.5 |
11.6 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.5 |
16.2 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.5 |
4.2 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.5 |
14.5 |
GO:0007127 |
meiosis I(GO:0007127) |
| 0.5 |
11.6 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.5 |
3.7 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.5 |
2.8 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.5 |
2.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.5 |
3.2 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.5 |
3.7 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.5 |
1.8 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.5 |
1.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.5 |
1.8 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.4 |
1.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.4 |
3.5 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 |
38.1 |
GO:0001841 |
neural tube formation(GO:0001841) |
| 0.4 |
0.9 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.4 |
1.3 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.4 |
1.7 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.4 |
13.8 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.4 |
2.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.4 |
0.4 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.4 |
7.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.4 |
9.8 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.4 |
6.8 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.4 |
1.3 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.4 |
2.9 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.4 |
2.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.4 |
0.8 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.4 |
1.2 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.4 |
5.7 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.4 |
0.8 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 |
8.0 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.4 |
4.8 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.4 |
9.9 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.4 |
5.8 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.4 |
0.8 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.4 |
1.9 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.4 |
4.6 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.4 |
9.5 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.4 |
4.6 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.4 |
3.0 |
GO:0031570 |
DNA integrity checkpoint(GO:0031570) |
| 0.4 |
17.6 |
GO:0071426 |
ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.4 |
9.6 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.4 |
2.6 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.4 |
3.7 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.4 |
21.5 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.4 |
9.8 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.4 |
1.8 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.4 |
3.9 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.4 |
2.1 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.3 |
0.7 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.3 |
0.7 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.3 |
1.7 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.3 |
2.0 |
GO:0002478 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
| 0.3 |
1.3 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) synaptic vesicle docking(GO:0016081) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.3 |
1.3 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 |
1.6 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.3 |
1.6 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
11.1 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.3 |
8.0 |
GO:0035307 |
positive regulation of protein dephosphorylation(GO:0035307) |
| 0.3 |
5.4 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.3 |
7.8 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.3 |
2.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.3 |
2.4 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.3 |
6.2 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.3 |
2.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 |
10.3 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.3 |
2.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 |
3.7 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.3 |
6.7 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.3 |
1.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.3 |
3.0 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 |
8.8 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.3 |
10.7 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.3 |
0.8 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
0.5 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.3 |
0.5 |
GO:0098532 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
1.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.3 |
0.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 |
3.2 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
0.2 |
GO:2001245 |
positive regulation of phospholipid biosynthetic process(GO:0071073) regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.2 |
1.0 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.2 |
2.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
3.4 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.2 |
1.4 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.2 |
7.2 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.2 |
6.7 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.2 |
3.0 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) |
| 0.2 |
3.2 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.2 |
0.9 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.2 |
1.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.9 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) positive regulation of protein depolymerization(GO:1901881) |
| 0.2 |
1.3 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.2 |
2.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.2 |
1.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 |
0.6 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.2 |
0.6 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.2 |
4.3 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.2 |
0.4 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.2 |
2.0 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.2 |
1.8 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.2 |
3.1 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 |
4.7 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.2 |
9.3 |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.2 |
0.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.2 |
1.3 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.2 |
7.0 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.2 |
1.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
1.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 |
0.7 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.2 |
0.7 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
1.8 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.2 |
0.3 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.2 |
1.7 |
GO:0060261 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 |
1.4 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.2 |
2.0 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.2 |
0.8 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
0.3 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.2 |
2.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
0.8 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
1.8 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.4 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
2.2 |
GO:0097006 |
regulation of plasma lipoprotein particle levels(GO:0097006) |
| 0.1 |
1.7 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
1.1 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 |
2.1 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.6 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.1 |
2.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.7 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
3.0 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
2.6 |
GO:0051321 |
meiotic cell cycle(GO:0051321) |
| 0.1 |
0.9 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 |
0.5 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
1.6 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.1 |
4.3 |
GO:0071356 |
cellular response to tumor necrosis factor(GO:0071356) |
| 0.1 |
0.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.1 |
5.9 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
1.0 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.5 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.4 |
GO:0006641 |
triglyceride metabolic process(GO:0006641) |
| 0.1 |
0.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.3 |
GO:0009130 |
pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
| 0.1 |
0.4 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
3.2 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.2 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
1.7 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.1 |
1.6 |
GO:0003281 |
ventricular septum development(GO:0003281) |
| 0.1 |
4.4 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.5 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
2.4 |
GO:0060021 |
palate development(GO:0060021) |
| 0.1 |
1.6 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.1 |
1.5 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
8.3 |
GO:0030100 |
regulation of endocytosis(GO:0030100) |
| 0.1 |
0.3 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.2 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
2.7 |
GO:0045137 |
development of primary sexual characteristics(GO:0045137) |
| 0.1 |
0.1 |
GO:0071028 |
RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
1.2 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.2 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
3.1 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.4 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
11.9 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.1 |
GO:0010564 |
regulation of cell cycle process(GO:0010564) |
| 0.0 |
0.2 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 |
0.1 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.4 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.2 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.0 |
GO:0072173 |
metanephric tubule morphogenesis(GO:0072173) |
| 0.0 |
0.6 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.5 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.0 |
0.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.2 |
GO:0045471 |
response to ethanol(GO:0045471) |
| 0.0 |
0.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.2 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.0 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 |
0.1 |
GO:0060767 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.0 |
0.1 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.0 |
GO:0009838 |
abscission(GO:0009838) |
| 0.0 |
0.1 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.0 |
0.4 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.2 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
